W.R. Berkley’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.5M Hold
322,658
– – 0.16% 140
2026
Q2
$3.45M Buy
322,658
+49,708
+18% +$531K 0.16% 121
2026
Q1
$2.89M Buy
272,950
+99,420
+57% +$1.05M 0.16% 135
2025
Q4
$1.82M Hold
173,530
– – 0.09% 159
2025
Q3
$1.79M Hold
173,530
– – 0.1% 147
2025
Q2
$1.78M Hold
173,530
– – 0.09% 150
2025
Q1
$1.75M Buy
+173,530
New +$1.74M 0.1% 111

Other funds holding TDAC

W.R. Berkley's TDAC Position: Q3 2026 in Review

W.R. Berkley held its Translational Development Acquisition Corp (TDAC) position steady in Q3 2026 at 322,658 shares worth $3.5M. The position accounts for 0.16% of the portfolio, ranked #140.

W.R. Berkley first reported a position in TDAC in Q1 2025 and has held it in 7 quarters since. 37 funds tracked by Wall St. Rank hold TDAC as of Q3 2026.

  • W.R. Berkley held 322,658 shares of Translational Development Acquisition Corp worth $3.5M as of Q3 2026.
  • W.R. Berkley left its Translational Development Acquisition Corp share count unchanged in Q3 2026.
  • Translational Development Acquisition Corp made up 0.16% of W.R. Berkley's portfolio in Q3 2026, its #140 holding.
  • W.R. Berkley first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 7 quarters since.
  • 37 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q3 2026.

Based on W.R. Berkley's 13F filing for Q3 2026, filed 16 Nov 2026.